NeoGenomics Q3 Adj. EPS $0.07 Beats $0.05 Estimate, Sales $209.254M Beat $207.328M Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings Beats
NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 percent. This is a 133.33 percent increase over earnings of $0.03 per share from the same
NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 percent. This is a 133.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $209.254 million which beat the analyst consensus estimate of $207.328 million by 0.93 percent. This is a 11.43 percent increase over sales of $187.797 million the same period last year.